SCHEMBL9690374

SCHEMBL9690374

CCOC(=O)OC1=C(C)Nc2cc[nH]c(=O)c2C1c1cccs1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PKM P14618 2/20 0.46
ALDH1A1 P00352 6/20 0.45
KDM4E B2RXH2 6/20 0.45
HPGD P15428 4/20 0.45
HSD17B10 Q99714 3/20 0.45
TSHR P16473 2/20 0.45
LMNA P02545 2/20 0.44
POLB P06746 1/20 0.44
AGTR1 P30556 1/20 0.44
ADORA2B P29275 6/20 0.43
KMT2A Q03164 2/20 0.43
MAPT P10636 3/20 0.41
MEN1 O00255 1/20 0.41
L3MBTL1 Q9Y468 3/20 0.41
ALOX15 P16050 1/20 0.41
TP53 P04637 1/20 0.41
GLA P06280 1/20 0.41
GAA P10253 1/20 0.41
CASP1 P29466 1/20 0.41
CASP7 P55210 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10789635 0.85 KDM4E (0.58) PKMALDH1A1KDM4EHPGDHSD17B10
SCHEMBL9690862 0.82 ALDH1A1 (0.54) PKMALDH1A1KDM4EHPGDHSD17B10
SCHEMBL10502956 0.81 KDM4E (0.51) ALDH1A1KDM4EHPGDHSD17B10LMNA
SCHEMBL10502995 0.80 TSHR (0.47) ALDH1A1KDM4EHPGDHSD17B10TSHR
SCHEMBL10502213 0.80 GAA (0.40) ALDH1A1KDM4EHSD17B10TSHRLMNA
SCHEMBL11035332 0.80 DHFR (0.44) PKMALDH1A1KDM4EHPGDHSD17B10
SCHEMBL10683747 0.79 ALDH1A1 (0.44) PKMALDH1A1KDM4EHPGDHSD17B10
SCHEMBL11001264 0.79 CYP2C9 (0.49) ALDH1A1KDM4EHPGDHSD17B10TSHR
SCHEMBL10503699 0.78 CACNA1F (0.41) TP53
SCHEMBL10746130 0.78 ACHE (0.43)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0234516-B1 1,6-NAPHTHYRIDINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND MEDICINE CONTAINING THEM FOR THE TREATMENT OF VASCULAR DISEASES GÖDECKE AKTIENGESELLSCHAFT (DE) 1992-04-29 EP disclosed
EP-0133530-B1 1,6-NAPHTHYRIDINONE DERIVATIVES, PROCESS FOR THEIR PREPARATION, AND MEDICAMENTS CONTAINING THEM GÖDECKE AKTIENGESELLSCHAFT (DE) 1989-03-15 EP disclosed
EP-0234516-A1 1,6-Naphthyridine derivatives, process for their preparation and medicine containing them for the treatment of vascular diseases GÖDECKE AKTIENGESELLSCHAFT (DE) 1987-09-02 EP disclosed